AU3372200A - Antibodies against hydrophobic proteins that are protective against candidiasis - Google Patents

Antibodies against hydrophobic proteins that are protective against candidiasis

Info

Publication number
AU3372200A
AU3372200A AU33722/00A AU3372200A AU3372200A AU 3372200 A AU3372200 A AU 3372200A AU 33722/00 A AU33722/00 A AU 33722/00A AU 3372200 A AU3372200 A AU 3372200A AU 3372200 A AU3372200 A AU 3372200A
Authority
AU
Australia
Prior art keywords
candidiasis
hydrophobic proteins
protective
antibodies against
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33722/00A
Inventor
Robert F Bargatze
Pati M. Glee
Kevin C. Hazen
James Masuoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UVA Licensing and Ventures Group
Takeda Vaccines Montana Inc
Original Assignee
University of Virginia UVA
University of Virginia Patent Foundation
Ligocyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia UVA, University of Virginia Patent Foundation, Ligocyte Pharmaceuticals Inc filed Critical University of Virginia UVA
Publication of AU3372200A publication Critical patent/AU3372200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU33722/00A 1999-02-19 2000-02-18 Antibodies against hydrophobic proteins that are protective against candidiasis Abandoned AU3372200A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US12076599P 1999-02-19 1999-02-19
US12076499P 1999-02-19 1999-02-19
US60120764 1999-02-19
US60120765 1999-02-19
US12221699P 1999-03-01 1999-03-01
US60122216 1999-03-01
PCT/US2000/004447 WO2000048633A1 (en) 1999-02-19 2000-02-18 Antibodies against hydrophobic proteins that are protective against candidiasis

Publications (1)

Publication Number Publication Date
AU3372200A true AU3372200A (en) 2000-09-04

Family

ID=27382520

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33722/00A Abandoned AU3372200A (en) 1999-02-19 2000-02-18 Antibodies against hydrophobic proteins that are protective against candidiasis

Country Status (2)

Country Link
AU (1) AU3372200A (en)
WO (1) WO2000048633A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2018164T1 (en) * 2006-05-12 2017-07-31 Christian Noe Use of combination preparations comprising antifungal agents
GB201503812D0 (en) 2015-03-06 2015-04-22 Univ Aberdeen Antibody molecules and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2657495A (en) * 1994-05-23 1995-12-18 Research And Development Institute, Inc. Candida albicans adhesin as a vaccine
US5641760A (en) * 1994-06-17 1997-06-24 Pence, Inc. Method of treating candida infection

Also Published As

Publication number Publication date
WO2000048633A1 (en) 2000-08-24
WO2000048633A9 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU1701001A (en) Antibodies against signal regulator proteins
AU1290001A (en) Antibodies
AU5173400A (en) Protein kinases
AU4935000A (en) Antibodies
AU1550300A (en) Antigen-binding proteins
AU1951201A (en) Peptide antigens
AU6045900A (en) Interaction-activated proteins
AU4228699A (en) Cellular proteins which mediate herpesvirus entry
AU5441000A (en) Human monoclonal antibody
AU6223700A (en) Gtp-binding associated proteins
AU3393900A (en) Human secretory proteins
AU2452301A (en) Protein methylarginine-specific antibodies
AU4299200A (en) Non-crosslinked polyethene
AU5706000A (en) Useful polypeptide
AU7508100A (en) Human seizure related proteins
AU3372200A (en) Antibodies against hydrophobic proteins that are protective against candidiasis
AU3861800A (en) Antibodies against phosphomannan that are protective against candidiasis
AU4352000A (en) Clasp-2 transmembrane proteins
AU2169201A (en) Method for the isolation of hydrophobic proteins
AU1881200A (en) Novel proteins
AU2136401A (en) P450rai-2 and related proteins
AU6911300A (en) Isomerase proteins
AU6983000A (en) Chimeric proteins
AU4245500A (en) Protein transport assays
AU3506800A (en) Leukocyte- and blood-associated proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase